Health Dictionary Find a Doctor

Fournier gangrene medical therapy

Steven C. Campbell, M.D., Ph.D.; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[1]; Jesus Rosario Hernandez, M.D. [2]

Overview

Overview

Fournier gangrene is a urological emergency requiring intravenous antibiotics and debridement (surgical removal) of necrotic (dead) tissue. Despite such measures, the mortality rate overall is 40%, but 78% if sepsis is already present at the time of initial hospital admission.[1] The spread of gangrene is rapid at the rate of 2–3 cm/h, hence early diagnosis and emergency surgical treatment is important.[2]

Medical Therapy

Medical Therapy

Fournier gangrene is a urological emergency requiring intravenous antibiotics and debridement (surgical removal) of necrotic (dead) tissue. Despite such measures, the mortality rate overall is 40%, but 78% if sepsis is already present at the time of initial hospital admission.[1] The spread of gangrene is rapid at the rate of 2–3 cm/h, hence early diagnosis and emergency surgical treatment is important.[2]

Antimicrobial Therapy

  • Fournier gangrene[3]
  • If caused by streptococcus species or clostridia
  • Polymicrobial
  • MRSA (methicillin resistant staphylococcus aureus) suspected

Nutritional Support

The metabolic demands of Fournier gangrene patients are similar to those of other major trauma or burns.[4] Nutritional support to replace lost proteins and fluids from large wounds and/or the result of shock is required from the first day of a patient’s hospital admission.

Hyperbaric oxygen

Contraindications to hyperbaric oxygen are:[8][9]

Side effects of hyperbaric oxygen are:

IV γ-globulin

References

References

  1. 1.0 1.1 Yanar H, Taviloglu K, Ertekin C, Guloglu R, Zorba U, Cabioglu N; et al. (2006). “Fournier’s gangrene: risk factors and strategies for management”. World J Surg. 30 (9): 1750–4. doi:10.1007/s00268-005-0777-3. PMID 16927060.
  2. 2.0 2.1 Paty R, Smith AD (1992). “Gangrene and Fournier’s gangrene”. Urol Clin North Am. 19 (1): 149–62. PMID 1736475.
  3. Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.
  4. Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A (2014). “Current concepts in the management of necrotizing fasciitis”. Front Surg. 1: 36. doi:10.3389/fsurg.2014.00036. PMC 4286984. PMID 25593960.
  5. Escobar SJ, Slade JB, Hunt TK, Cianci P (2005). “Adjuvant hyperbaric oxygen therapy (HBO2)for treatment of necrotizing fasciitis reduces mortality and amputation rate”. Undersea Hyperb Med. 32 (6): 437–43. PMID 16509286.
  6. Korhonen K (2000). “Hyperbaric oxygen therapy in acute necrotizing infections with a special reference to the effects on tissue gas tensions”. Ann Chir Gynaecol Suppl (214): 7–36. PMID 11199291.
  7. Hyperbaric oxygen therapy. http://onlinelibrary.wiley.com/doi/10.1080/110241500750008583/abstract (2016) Accessed on September 12, 2016
  8. Kindwall EP, Gottlieb LJ, Larson DL (1991). “Hyperbaric oxygen therapy in plastic surgery: a review article”. Plast Reconstr Surg. 88 (5): 898–908. PMID 1924583.
  9. Capelli-Schellpfeffer M, Gerber GS (1999). “The use of hyperbaric oxygen in urology”. J Urol. 162 (3 Pt 1): 647–54. PMID 10458334.
  10. Darabi K, Abdel-Wahab O, Dzik WH (2006). “Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature”. Transfusion. 46 (5): 741–53. doi:10.1111/j.1537-2995.2006.00792.x. PMID 16686841.

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH